Smart Insulin: An Overview of All Projects

December 13, 2018

This report provides an overview of all smart insulin projects, also known as glucose-responsive insulin. Click here to read more.

The Edmonton Protocol Turns 20: What Have We Learned?

December 6, 2018

Twenty years have passed since the Edmonton Protocol for islet cell transplantation (ICT) was published in the New England Journal of Medicine. This report will review the research and learning over the twenty year period and highlight the main achievements and ongoing challenges for ICT. Click here to read more.

How to Make your T1D Donation Truly Count: The 4S's of Good Giving

November 8, 2018

In this article, we share a disciplined strategy that helps to increase the impact of any charitable gift. Click here to read more.

Helmsley: The quiet powerhouse in t1d research

October 25, 2018

This report provides an overview of the Leona M. and Harry B. Helmsley Charitable Trust and their extraordinary commitment to T1D. Click here to read more.

what must change to achieve a practical cure in 15 years

October 18, 2018

This report outlines the paradigm shift necessary for the T1D research and fundraising community to achieve a Practical Cure for type 1 diabetes within the next 15 years.  Click here to read more.

Cure Research Remains the Primary Reason People Participate in T1D Fundraising Walks

October 4, 2018

Based on a recent JDCA survey of the T1D community, the primary reason—by far—that people participate in diabetes fundraising walks is to fund cure research. Click here to read more.

Artificial pancreas projects in human trials by competitor

September 27, 2018

The JDCA evaluated each of the companies involved in AP human trials, points of differentiation amongst competitors, and both active and completed human trials. Click here to read more.

JDRF and ADA Fundraising Promise Inconsistent with Actual Spending

September 13, 2018

This is the seventh annual review of advertising messages used by the ADA and JDRF at national fundraising events. During 2018, the ADA and JDRF advertised for a total of 282 national events including walks, rides, and galas. Click here to read more.

JDRF Infographic: 2/3 of JDRF Revenue Never Makes it to T1D Research

August 30, 2018

This infographic explains how JDRF, the largest and most influential diabetes fundraising organizations in the U.S., uses its funds. Click here to read more.

ADA Infographic: Only 4% of Income Goes to T1D Research

August 23, 2018

This infographic provides a snapshot of how the ADA, one of the largest and most influential diabetes fundraising organizations in the U.S., uses its funds.  Click here to read more.

T1D Board of Directors: It's Time for Action

August 16, 2018

This report outlines JDCA's six recommendations for improving the performance of the Board of Directors at the ADA and JDRF. Click here to read more.

Executive pay at major t1d non-profits still not tied to cure progress

August 9, 2018

This is the seventh annual review of executive compensation for the top diabetes non-profits. The review focuses on the ADA and JDRF, the largest diabetes fundraising organizations, but also includes data for Joslin and the Diabetes Research Institute Foundation (DRIF), two other notable diabetes funding organizations we periodically cover. Click here to view. 

JDRF Research Grant Allocation During 2017

July 26, 2018

This is the sixth annual review of JDRF research grant allocations. The main purpose of reviewing and sharing this data is to assess how JDRF is addressing the number one priority of donors: finding a cure for T1D. Click here to view.

ADA 2017: Only 4% of income dedicated to T1D research grants

July 19, 2018

This report provides a review of the ADA's 2 statements. This is the sixth year that we have reviewed these financial documents. Click here to view.

The 20 Largest T1D Research Centers in the US

July 3, 2018

This report provides an overview of the top 20 type 1 diabetes (T1D) research centers ranked by T1D research budget size during 2016. Our analysis includes the three largest budget sources: The National Institute of Health (NIH); Juvenile Diabetes Research Foundation (JDRF); and major donations or gifts from independent sources. (Click here to view)

Update on the American Diabetes Association's 78th Sessions

June 27, 2018

The American Diabetes Association's 78th Scientific Sessions, the largest annual American diabetes research conference of the year, was held June 22-26 in Orlando, Florida. The JDCA attended the conference with the purpose of identifying advancements and news related to T1D Practical Cure research. Click here to view.

The JDRF T1D Fund One-Year Retrospective: A Valuable Initiative Hidden Behind a Wall of Secrecy

June 14, 2018

This report provides an overview of the JDRF T1D venture philanthropy fund now that it has been operating for a full year. Click here to view.

JDRF and ADA Leadership Announcements

June 7, 2018

This report provides a quick update on the ADA's new CEO, Tracey D. Brown, and JDRF's new Chairman of the International Board of Directors, Ellen Leake. Click here to view.

practical cure projects in fda human trials by pathway

June 1, 2018

This report reviews the 11 active Practical Cure research projects underway in United States FDA approved human clinical trials. Beyond the 11 active projects, there is also an appendix at the end of the report which outlines high-profile emerging Practical Cure projects. Click here to view.

The four research pathways to a practical cure for type 1 diabetes

May 24, 2018

This report defines the four Practical Cure research pathways. Click here to view.

An overview of all active t1d human trials

May 11, 2018

This is the sixth annual review of all active type 1 diabetes trials currently testing in humans. Each trial is classified into ten distinct categories. Click here to view.

"The Time is now." Naomi Berrie 2018 Research Panel Discussion

May 2, 2018

Yesterday, the Naomi Berrie Diabetes Center at Columbia University hosted a research panel discussion in New York City. Highlights of that meeting are presented in this report. Click here to view. 

An investigative report on stem cells arabia's poster results

April 20, 2018

This report provides an update on Stem Cells Arabia (SCA), a private company in Amman, Jordan that is conducting human trials research toward a T1D cure using the “Jordanian Method for Treatment of Diabetes.” Click here to view. 

New Encapsulation Approach Attracts Big Pharma Investment

April 12, 2018

Yesterday, a widely published press release announced a new partnership between Eli Lilly and Sigilon Therapeutics, a private biopharmaceutical company working on a unique cell encapsulation approach. Click here to view.

Practical Cure Update: Stem Cell Educator

March 22, 2018

This report provides an update on the Stem Cell Educator project and features an interview with the principal investigator Dr. Yong Zhao. Click here to view.

T1D Donor Survey: Cure Research is #1 Priority

March 8, 2018

This is the sixth annual survey-based report on the giving priorities of T1D donors. The key takeaway is the same as all prior years: the number one reason people make donations to diabetes charities and/or participate in fundraising activities such as walks and galas is to find a cure. Click here to read more.

JDRF Internal Costs for Administering Research Grants Remains at Three-Year High

February 22, 2018

This is a third in a series of reports on JDRF financials. The main takeaway is that JDRF administration cost for each dollar of actual research grants have increased 115 percent since 2008 while research grant spending is down 50 percent. Click here to read more.

JDRF 2017 Income and Use of Donor Dollars

February 8, 2018

This report analyzes the key sources of income for JDRF and the primary ways this money was used during 2017. Click here to read more.

JDRF Direct and influenced grant spending (as published by jdrf)

January 31, 2018

This report addresses an infographic in which JDRF claims it is responsible for $300 million dollars of research spending in 2017, rather than the $79 million reported in their audited financial statements. Click here to read more.


January 19, 2018

This report provides an overview of JDRF's 2017 financial statements, released this week. Based on publicly available tax and financial documents, it show how JDRF generates its revenue and how it utilizes those funds. Click here to read more. 

sernova encapsulation device starts human trials

January 12, 2018

This report will provide an overview of Sernova’s Pouch System in addition to an interview with the President and CEO, Philip Toleikis, Ph.D. Click here to read more.

2017 State of the cure for type 1 diabetes

January 4, 2017

This is the sixth annual edition of this report. It summarizes progress made during 2017 toward a Practical Cure for type 1 diabetes. Click here to read more.